Acute Intermittent Hypoxia in Persons With Multiple Sclerosis

Completed · Not applicable · Has a placebo group

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

The overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with relapsing-remitting MS.

Key facts

Study ID

NCT04280484

Run by

Shirley Ryan AbilityLab

People needed

10

Starts

2018-06-18

Expected to finish

2019-12-30

Last updated by the study team

2020-02-24

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have relapsing-remitting MS
• Volitional ankle plantar flexion strength in at least one leg
• Are relapse free for 30 days
• Patient-Determined Disease Steps scale score between 3 and 5 (3=gait disability to 5=late cane, need cane to walk 25 feet)

You may not qualify if…

• Currently taking antispasticity medications,
• Have cardiovascular or respiratory/pulmonary disorders, metabolic dysfunction, or prior diagnoses of obstructive sleep apnea
• Pregnant or nursing women (safety for developing fetus or infant is unknown)
• Cognitive concerns (must be able to consent to study, follow steps)

Where it is running

• Shirley Ryan AbilityLab — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.